Pyrrolotriazines as Novel Potent ALK Inhibitors
EML4-ALK: Oncogene Addiction Meets Personalized Medicine Thomas J Lynch, MD Jonathan and Richard Sackler Professor of Internal Medicine Director, Yale.
